Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey

ALTUNTAŞ, TÜRKER; Şahin, Bahadır; Onur, Rahmi; Kütükoğlu, Mehmet umut

doi:10.55730/1300-0144.5575

Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey

Mehmet Umut KÜTÜKOĞLU, (Marmara Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, İstanbul, Türkiye)

Türker ALTUNTAŞ, (Marmara Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, İstanbul, Türkiye)

Bahadır ŞAHİN, (Marmara Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, İstanbul, Türkiye)

Rahmi ONUR (Marmara Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, İstanbul, Türkiye)

Turkish Journal of Medical Sciences

3 1

Yıl: 2023 Cilt: 53 Sayı: 1 Sayfa Aralığı: 211 - 217 Metin Dili: İngilizce DOI: 10.55730/1300-0144.5575 İndeks Tarihi: 28-03-2023

Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey

Öz:

Background/aim: Sacral neuromodulation (SNM) is a minimally invasive treatment that modulates spinal reflexes to regulate bladder, urinary sphincter, and pelvic floor and has successfully been used in the treatment of refractory voiding dysfunctions. The aim of this study was to present our experience with SNM in a tertiary referral center with the largest number of patients and review the safety and efficacy of the procedure. Materials and methods: A total of 42 patients with refractory lower urinary tract symptoms were included into the study. After an initial test period, patients who showed more than 50% improvement in their symptoms underwent the second stage of SNM. Twelve patients had overactive bladder (OAB), bladder pain syndrome/interstitial cystitis (BPS/IC) and 17 had urinary retention. The clinical success was examined during follow-up by voiding diary, urodynamics, and global response assessment. Results: Between February 2015 and December 2020, a total of 29 patients underwent stages I&II SNM procedures. The mean ages of patients in OAB/BPS group and retention group were 40 (37–57 years) and 35 (27–44 years), respectively. Mean follow-up time was at least 1 year. Overall, 58.5% success rate was observed in OAB, BPS/IC, and urinary retention groups. Global response assessment score in both groups increased significantly (p = 0.001). No statistically significant difference was found between success or failure rates when sex and age were variable parameters (p > 0.05). Conclusion: SNM appears to be an effective and safe treatment option in restoring voiding dysfunctions in patients with refractory idiopathic and neurogenic voiding dysfunctions. Our initial series revealed favorable results; however, further studies with larger series and longer follow-up are needed.

Anahtar Kelime: Sacral neuromodulation efficacy voiding dysfunction treatment

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Tahseen S. Role of sacral neuromodulation in modern urogynecology practice: A review of recent literature. International Urogynecology Journal 2018; 29 (8): 1081- 1091. https://doi.org/10.1007/s00192-017-3546-6
2. Elterman DS, Chughtai B, Vertosick E, Thomas D, Eastham J et al. Trends and clinical practice patterns of sacral Neuromodulation for overactive bladder. Female Pelvic Medicine & Reconstructive Surgery Jul/Aug 2018; 24 (4): 264- 266. https://doi.org/10.1097/spv.0000000000000449
3. Liberman D, Ehlert MJ, Siegel SW. Sacral neuromodulation in urological practice. Urology 2017; 99: 14-22. https://doi. org/10.1016/j.urology.2016.06.004
4. Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castaño Botero JC et al. International Continence Society best practice statement for use of sacral neuromodulation. Neurourology and Urodynamics 2018; 37 (5): 1823-1848. https://doi.org/10.1002/ nau.23515
5. Zhang P, Wang JY, Zhang Y, Liao L, Ling Q et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: Five-year experience of a retrospective, multicenter study in China. Neuromodulation: Technology at the Neural Interface 2019 Aug; 22 (6): 730-737. https://doi. org/10.1111/ner.12902
6. Oelke M, Addali M, Reisenauer C. What uro-gynecologists should know about sacral neuromodulation (SNM) for the treatment of refractory overactive bladder. Archives of Gynecology and Obstetrics 2019 May; 299 (5): 1243- 1252. https://doi.org/10.1007/s00404-019-05127-7
7. Hoag N, Plagakis S, Pillay S, Edwards AW, Gani J. Sacral neuromodulation for refractory overactive bladder after prior intravesical on a botulinumtoxinA treatment. Neurourology and Urodynamics 2016; 36 (5): 1377-1381. https://doi. org/10.1002/nau.23117
8. Marcelissen T, Jacobs R, Van Kerrebroeck P, De Wachter S. Sacral neuromodulation as a treatment for chronic pelvic pain. The Journal of Urology 2011; 186 (2): 387-393. https://doi. org/10.1016/j.juro.2011.02.2694
9. Matzel KE, Chartier-Kastler E, Knowles CH, Lehur PA, Muñoz- Duyos A et al. Sacral Neuromodulation: Standardized electrode placement technique. Neuromodulation: Technology at the Neural Interface 2017; 20 (8): 816-824. https://doi.org/10.1111/ ner.12695
10. Siegel SW, Moeller SE. Sacral Neuromodulation for the Treatment of Overactive Bladder (OAB). In: Raz S, Rodriquez L (editors). Female Urology. 3rd ed. Ch. 22. Philadelphia, PA, USA: WB Saunders Company; 2008. pp. 266-276.
11. Fariello JY, Whitmore K. Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction. International Urogynecology Journal 2010; 21 (12): 1553- 1558. https://doi.org/10.1007/s00192-010-1281-3
12. Apostolidis A, Dasgupta P, Denys P, Elneil S, Fowler CJ et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: A European Consensus Report. European Urology 2009; 55 (1) 100-120. https://doi.org/10.1016/j. eururo.2008.09.009
13. Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU Guideline Amendment. The Journal of Urology 2015; 193 (5): 1572-1580. https://doi.org/10.1016/j. juro.2015.01.087
14. Kessler TM, Madersbacher H, Kiss G. Prolonged sacral neuromodulation testing using permanent leads: A more reliable patient selection method? European Urology 2005; 47 (5): 660-665. https://doi.org/10.1016/j.eururo.2004.11.005
15. Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: A systematic review. The Journal of Urology 2006; 175 (3): 835-841. https:// doi.org/10.1016/s0022-5347(05)00326-5
16. Peeters K, Sahai A, De Ridder D, Van Der F. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU International 2014; 113 (5): 789-794. https:// doi.org/10.1111/bju.12571
17. Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE et al. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourology and Urodynamics 2014; 35 (2): 246-251. https:// doi.org/10.1002/nau.22707
18. Van K, Philip EV, Marcelissen TA. Sacral neuromodulation for lower urinary tract dysfunction. World Journal of Urology 2011; 30 (4): 445-450. https://doi.org/10.1007/s00345-011- 0780-2
19. Al-Azzawi IS, Al-Tamimi MAJ. The first Iraqi experience in sacral neuromodulation for patients with lower urinary tract dysfunction. Arab Journal of Urology 2018; 16 (4): 391-396. https://doi.org/10.1016/j.aju.2018.05.006
20. Jonas U, Fowler CJ, Chancellor MB, Elhılalı MM, Fall JB et al. Efficacy of sacral nerve stimulation for urinary retention: results
18 months after implantation. The Journal of Urology 2001; 165 (1): 15-19. https://doi.org/10.1097/00005392-200101000-00004 21. Gross C, Habli M, Lindsell C, South M. Sacral neuromodulation for nonobstructive urinary retention. Female Pelvic Medicine & Reconstructive Surgery 2010; 16 (4): 249-253. https://doi. org/10.1097/spv.0b013e3181df9b3f
22. Peeters K, Sahai A, De Ridder D, Van Der AF. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU International 2014; 113 (5): 789-794. https:// doi.org/10.1111/bju.12571
23. Redshaw JD, Lenherr SM, Elliott SP, Stoffel JT, Rosenbluth et al. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury. BMC Urology 2018; 18 (1): 4-7. https://doi.org/10.1186/s12894-018- 0383-y
24. Drake MJ, Apostolidis A, Cocci A, Emmanuel A, Gajewski JB et al. Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the neurologic incontinence committee of the fifth international consultation on incontinence 2013. Neurourology and Urodynamics 2016; 35 (6): 657-665. https://doi.org/10.1002/nau.23027
25. Pannek J, Blok B, Castro-Diaz D. Guidelines on neurogenic lower urinary tract dysfunction. European Association of Urology 2009; 56 (1): 81-88. https://doi.org/10.1016/j. eururo.2009.04.028
26. Burks FN, Bui DT, Peters KM. Neuromodulation and the neurogenic bladder. Urologic Clinics of North America 2010; 37 (4): 559-565. https://doi.org/10.1016/j.ucl.2010.06.007
27. Hijaz A, Vasavada SP, Daneshgari F, Frinjari H, Goldman H et al. Complications and troubleshooting of two-stage sacral neuromodulation therapy: A single-institution experience. The Journal of Urology 2006; 68 (3): 533-537. https://doi. org/10.1016/j.urology.2006.03.020
28. Rios LAS, Averbeck MA, França W, Sacomani CAR, Almeida FG et al. Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in Brazil. International Brazilian Journal of Urology 2016; 42 (2): 312- 320. https://doi.org/10.1590/s1677-5538.ibju.2014.0603

APA	Kütükoğlu M, ALTUNTAŞ T, Şahin B, Onur R (2023). Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. , 211 - 217. 10.55730/1300-0144.5575
Chicago	Kütükoğlu Mehmet umut,ALTUNTAŞ TÜRKER,Şahin Bahadır,Onur Rahmi Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. (2023): 211 - 217. 10.55730/1300-0144.5575
MLA	Kütükoğlu Mehmet umut,ALTUNTAŞ TÜRKER,Şahin Bahadır,Onur Rahmi Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. , 2023, ss.211 - 217. 10.55730/1300-0144.5575
AMA	Kütükoğlu M,ALTUNTAŞ T,Şahin B,Onur R Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. . 2023; 211 - 217. 10.55730/1300-0144.5575
Vancouver	Kütükoğlu M,ALTUNTAŞ T,Şahin B,Onur R Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. . 2023; 211 - 217. 10.55730/1300-0144.5575
IEEE	Kütükoğlu M,ALTUNTAŞ T,Şahin B,Onur R "Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey." , ss.211 - 217, 2023. 10.55730/1300-0144.5575
ISNAD	Kütükoğlu, Mehmet umut vd. "Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey". (2023), 211-217. https://doi.org/10.55730/1300-0144.5575

APA	Kütükoğlu M, ALTUNTAŞ T, Şahin B, Onur R (2023). Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. Turkish Journal of Medical Sciences, 53(1), 211 - 217. 10.55730/1300-0144.5575
Chicago	Kütükoğlu Mehmet umut,ALTUNTAŞ TÜRKER,Şahin Bahadır,Onur Rahmi Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. Turkish Journal of Medical Sciences 53, no.1 (2023): 211 - 217. 10.55730/1300-0144.5575
MLA	Kütükoğlu Mehmet umut,ALTUNTAŞ TÜRKER,Şahin Bahadır,Onur Rahmi Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. Turkish Journal of Medical Sciences, vol.53, no.1, 2023, ss.211 - 217. 10.55730/1300-0144.5575
AMA	Kütükoğlu M,ALTUNTAŞ T,Şahin B,Onur R Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. Turkish Journal of Medical Sciences. 2023; 53(1): 211 - 217. 10.55730/1300-0144.5575
Vancouver	Kütükoğlu M,ALTUNTAŞ T,Şahin B,Onur R Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey. Turkish Journal of Medical Sciences. 2023; 53(1): 211 - 217. 10.55730/1300-0144.5575
IEEE	Kütükoğlu M,ALTUNTAŞ T,Şahin B,Onur R "Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey." Turkish Journal of Medical Sciences, 53, ss.211 - 217, 2023. 10.55730/1300-0144.5575
ISNAD	Kütükoğlu, Mehmet umut vd. "Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey". Turkish Journal of Medical Sciences 53/1 (2023), 211-217. https://doi.org/10.55730/1300-0144.5575